Cargando…

Use of single-agent pembrolizumab as first-line treatment for non-small cell lung cancer with PDL1 status 50% as per NHS England interim guidance during the COVID-19 pandemic at Southend University Hospital

Detalles Bibliográficos
Autores principales:	Sen, Rebecca, Islam, Rafiqul Islam, Baker, Harriet, Kim, Samuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. Published by Elsevier B.V. 2021
Materias:	COVID and Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159539/ http://dx.doi.org/10.1016/S0169-5002(21)00241-5

Ejemplares similares

Looking a Gift Horse in the Mouth: Observations on NHS England's Interim Guidance on Pembrolizumab in Head and Neck Squamous Cell Cancer
por: Harrington, K.J., et al.
Publicado: (2020)

The impact of the COVID-19 pandemic on pleural activity at Plymouth NHS Trust
por: McDill, Helen, et al.
Publicado: (2021)

The impact of the COVID-19 pandemic on lung cancer diagnosis and stage at Plymouth NHS Trust
por: McDill, Helen, et al.
Publicado: (2021)

Southend and Its Medical Officer
Publicado: (1907)

Impact of the COVID-19 pandemic on suspected lung cancer referrals and subsequent lung cancer diagnoses at North Bristol NHS Trust (NBT)
por: Coombs, Catherine, et al.
Publicado: (2022)

Analysis of the source of lung cancer diagnoses during 2020 COVID-19 pandemic compared with 2015-2019 in the York and Scarborough NHS Trust
por: Watchorn, Hazel
Publicado: (2021)

Evidence is Lacking for the NHS England Interim Guidance for Managing Metastatic Non-small Cell Lung Cancer in the COVID-19 Pandemic
por: Choudhury, M., et al.
Publicado: (2021)

The impact of the Covid-19 pandemic on lung cancer incidence in England: an analysis of the 2019 and 2020 Rapid Cancer Registration Datasets
por: Gysling, Savannah, et al.
Publicado: (2022)

Use of systemic anti-cancer treatments in advanced stage non-small cell lung cancer during the SARS-CoV-2 pandemic in England and Wales: an analysis of the Rapid Cancer Registration Dataset
por: Morgan, Helen, et al.
Publicado: (2022)

Hyperprogression in PDL1 Expressive, Recurrent Gastroesophageal-junction Adenocarcinoma After Pembrolizumab
por: Sama, Shashank, et al.
Publicado: (2019)

Impact of COVID-19 on Colorectal Cancer Patients at Basildon and Southend University Hospitals
por: Abdalla Al-Zawi, Abdalla Saad, et al.
Publicado: (2022)

An interim review of the epidemiological characteristics of 2019 novel coronavirus
por: Ryu, Sukhyun, et al.
Publicado: (2020)

New PDL1 inhibitors for non-small cell lung cancer: focus on pembrolizumab
por: Bylicki, Olivier, et al.
Publicado: (2018)

Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects
por: Bai, Haiyan, et al.
Publicado: (2023)

The NHS: The Next 50 Years
por: Langlands, Alan
Publicado: (1998)

Quality improvement in Respiratory Medicine: Designing and implementing a bronchoscopy checklist at Southend University Hospital
por: Thillai, Muhunthan, et al.
Publicado: (2013)

Ethnic differences in COVID-19 mortality during the first two waves of the Coronavirus Pandemic: a nationwide cohort study of 29 million adults in England
por: Nafilyan, Vahé, et al.
Publicado: (2021)

COVID-19 and Pembrolizumab-Induced Secondary Hemophagocytic Lymphohistiocytosis: a Case Report
por: Ramos-Ruperto, Luis, et al.
Publicado: (2021)

How has the coronavirus pandemic impacted chemoradiotherapy for stage 3 non-small cell lung cancer (NSCLC) in our centre?
por: Kathirgamakarthigeyan, Sangary, et al.
Publicado: (2022)

The continued impact of the COVID-19 pandemic on patient advocacy and support organisations in the UK and Ireland: results from the second Global Lung Cancer Coalition (GLCC) survey
por: McNamara, Aoife, et al.
Publicado: (2022)

Incidence and outcomes of central airway obstruction in new lung cancer diagnoses prior to and during COVID-19
por: Zaki, Irfan, et al.
Publicado: (2022)

The impact of COVID-19 on national targets in radical lung cancer radiotherapy: a single centre clinical audit
por: Durno, Kimberley, et al.
Publicado: (2022)

Assessment of the impact of SARS-CoV-2 PCR results amongst thoracic oncology patients
por: Greenwood, Helene, et al.
Publicado: (2022)

Contact with lung cancer patients during COVID-19: findings from Ireland and the UK from a global survey of patient experience
por: McNamara, Aoife, et al.
Publicado: (2022)

The effects of COVID-19 pandemic on lung cancer diagnosis
por: Sinthiya, Mariya, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic first wave on the volume and type of systemic anticancer therapy (SACT) delivered for thoracic malignancies
por: Decatris, Marios, et al.
Publicado: (2022)

The impact of virtual lung MDT meetings (MDTMs) in response to the COVID-19 pandemic
por: Groothuizen, Hanna, et al.
Publicado: (2022)

No evidence of increased susceptibility to COVID-19 virus among radical lung radiotherapy patients
por: Lepiarczyk, Oskar, et al.
Publicado: (2021)

Does the use of primary care spirometry results in patients referred with suspected lung cancer have potential to avoid delays in the lung cancer referral pathway as a result of the SARS-COV-2 pandemic?
por: Ni Chleirigh, Romy, et al.
Publicado: (2021)

The impact of SARS-COV-2 pandemic on pleural services, diagnosis of malignant effusions and junior doctors’ procedural training
por: Riddell, Nathan, et al.
Publicado: (2021)

Changes in management for patients with lung cancer referred for radical radiotherapy during the first wave of the COVID 19 pandemic in the UK (COVID-RT Lung)
por: Banfill, Kathryn Banfill, et al.
Publicado: (2021)

Evaluation of telephone consultations for follow up lung cancer patients at Royal Papworth Hospital, undertaken instead of face-to-face consultations during the Covid-19 pandemic
por: Haslop, Claire, et al.
Publicado: (2021)

The impact of the COVID-19 pandemic on patient advocacy and support organisations in the UK and Ireland – results from a Global Lung Cancer Coalition (GLCC) survey
por: Dallas, Lorraine, et al.
Publicado: (2021)

Lung cancer upstaging due to the COVID-19 pandemic
por: Vella, Claire, et al.
Publicado: (2021)

Patient and physician opinion of virtual care in the oncology department of an Irish tertiary care centre in the era of Covid-19
por: O’Reilly, Mary, et al.
Publicado: (2021)

‘Your cough could be masking something else’ – raising awareness of lung cancer during the Covid-19 pandemic
por: Mc Namara, Aoife
Publicado: (2021)

Impact of the COVID-19 pandemic on the use of systemic anti-cancer therapy for patients diagnosed with malignancy at thoracoscopy in Aneurin Bevan University Health Board
por: Barton, Eleanor, et al.
Publicado: (2021)

Lung nodule management in Covid-19: does postponed surveillance matter?
por: Ratnakumar, Ratnaprashanthika, et al.
Publicado: (2021)

The impact of COVID-19 on lung cancer diagnostics – a multicentre comparison of 2019/2020 data
por: Navani, Neal, et al.
Publicado: (2021)

Impact of COVID-19 on mesothelioma clinical nurse specialists
por: Taylor, Bethany, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p537sahbd7iassjr5n5gvg3drt